Promoting Increases in Living Organ Donation via Tele-navigation (PILOT)
通过远程导航(PILOT)促进活体器官捐赠的增加
基本信息
- 批准号:10208150
- 负责人:
- 金额:$ 65.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAdvocacyAdvocateCellular PhoneCharacteristicsComplexConsumptionDiagnostic radiologic examinationDonor SelectionEducationEnsureEvaluationFamilyFrequenciesFriendsGeographyHealthcare SystemsIndividualInfrastructureInternetInterventionKidneyKidney TransplantationKnowledgeLiving DonorsMaintenanceMethodsModelingMonitorOrganOrgan DonationsParticipantPatientsPersonsPhysiciansProcessRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceRelationship-BuildingResearchResourcesRoleRuralServicesSourceSoutheastern United StatesSpeedSystemTechniquesTestingTimeTrainingTraining ProgramsTransplantationUnited StatesVisitbasecompare effectivenessdesignimprovedimproved outcomeliving kidney donorloved onesnovelprogramsrural areascreeningsmartphone Applicationstandard of caretelehealthtooltransplant centersurban setting
项目摘要
SUMMARY
The demand for kidney transplantation continues to greatly exceed the supply, and living kidney donors remain
a critical source of organs for their loved ones. Living donor kidney transplantation (LDKT) has decreased in
the US since 2004, and importantly, significant geographic disparities in likelihood of LDKT have been
identified, with the southeastern US having the lowest rates. Transplant candidate-related and potential living
donor-related factors, including difficulty asking family/friends to donate on one’s behalf and lack of knowledge
about the donation process, respectively, have been implicated in lower donation rates. Programs have been
developed to separate the advocacy role from the transplant candidate in order to overcome barriers
associated with asking someone to donate on one’s behalf, and have demonstrated increases in living donor
inquiries. Importantly, these programs were developed and implemented in resource-intense urban settings
that afforded ready access to high-speed internet, cell phone service and close geographic proximity to urban-
based transplant centers, limiting their generalizability to low-resource settings like the rural, southeastern US.
Moreover, these programs failed to include targeted interventions to improve potential living donor comfort with
the evaluation process, impeding sustained increases in LDKT. Living donor selection is a comprehensive
process that begins with potential donor inquiry, screening of potential donors for absolute contraindications to
donation (e.g. solitary kidney), evaluation, and ultimately approval. This process is time-consuming,
overwhelming, and involves complex and frequent interactions with the healthcare system. Not surprisingly,
many potential living donors withdraw from the process prior to approval and donation. Multiple studies have
demonstrated the feasibility and efficacy of patient navigator programs in improving outcomes, including more
efficient use of healthcare systems. In order to address knowledge gaps within existing programs designed to
increase living donation, we utilized the RE-AIM framework to develop and implement a novel Living Donor
Navigator Program (LDN). LDN combines advocacy-training to overcome barriers in initiating conversations
with and identification of potential living donors with the use of non-clinical navigators to guide donors through
the evaluation process. Early results indicate a 7-fold increase in likelihood of an approved donor among LDN
participants compared to non-participants; however, assessment of LDN reach and adoption demonstrated
that geographic disparities among participants exist. We hypothesize that expansion of the LDN program to
include telehealth delivery will overcome geographic disparities in access and facilitate sustained increases in
living donation. To this end, we will address the following aims: 1) Conduct qualitative assessments to identify
facilitators for LDN telehealth participation, 2) Implement a LDN telehealth program, and 3) Compare the
effectiveness of telehealth LDN model vs. standard of care for increasing living kidney donation.
总结
肾移植的需求继续大大超过供应,活体供肾者仍然存在。
为他们所爱的人提供重要的器官来源。活体供肾移植(LDKT)在2010年有所下降。
美国自2004年以来,重要的是,LDKT的可能性存在显著的地理差异,
美国东南部的发病率最低。移植候选人相关和潜在的生活
与捐赠者有关的因素,包括难以让家人/朋友代表自己捐赠以及缺乏知识
关于捐赠过程,分别与较低的捐赠率有关。方案已经
将倡导角色与移植候选人分开,以克服障碍
与要求某人代表某人捐赠有关,并且已经证明活体捐赠者的增加
询问。重要的是,这些方案是在资源密集型城市环境中制定和实施的
提供高速互联网和手机服务,地理位置靠近城市-
基于移植中心,限制他们的普遍性低资源设置,如农村,美国东南部。
此外,这些计划未能包括有针对性的干预措施,以改善潜在的活体捐赠者的舒适度,
评估进程,阻碍了LDKT的持续增长。活体捐赠者的选择是一个全面的
这个过程从潜在的捐赠者询问开始,筛选潜在的捐赠者的绝对禁忌症,
捐赠(例如,孤立肾)、评估和最终批准。这个过程很耗时,
压倒性的,并且涉及与医疗保健系统复杂且频繁的互动。毫不奇怪的是,
许多潜在的活体捐赠者在批准和捐赠之前退出该过程。多项研究
证明了患者导航程序在改善结果方面的可行性和有效性,包括更多
有效利用医疗保健系统。为了解决现有方案中的知识差距,
为了增加活体捐赠,我们利用RE-AIM框架开发和实施了一种新的活体捐赠者
导航程序(LDN)。LDN结合了沟通培训,以克服发起对话的障碍
通过使用非临床导航仪指导供体,
评估过程。早期结果表明,在LDN中获得批准的供体的可能性增加了7倍
参与者与非参与者相比;然而,对土地退化零增长覆盖率和采用率的评估表明,
参与者之间存在地域差异。我们假设LDN计划的扩展,
包括提供远程保健服务,将克服在获得服务方面地域差异,并促进
活体捐赠为此,我们将实现以下目标:1)进行定性评估,以确定
LDN远程医疗参与的促进者,2)实施LDN远程医疗计划,以及3)比较
远程医疗LDN模式与标准护理对增加活体肾脏捐献的有效性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAYME ELIZABETH LOCKE其他文献
JAYME ELIZABETH LOCKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAYME ELIZABETH LOCKE', 18)}}的其他基金
Promoting Increases in Living Organ Donation via Tele-navigation (PILOT)
通过远程导航(PILOT)促进活体器官捐赠的增加
- 批准号:
10379295 - 财政年份:2021
- 资助金额:
$ 65.34万 - 项目类别:
Promoting Increases in Living Organ Donation via Tele-navigation (PILOT)
通过远程导航(PILOT)促进活体器官捐赠的增加
- 批准号:
10576309 - 财政年份:2021
- 资助金额:
$ 65.34万 - 项目类别:
Genetic, Environmental & Histologic Basis for Kidney Disease Risk among Persons Living with HIV
遗传、环境
- 批准号:
10186736 - 财政年份:2018
- 资助金额:
$ 65.34万 - 项目类别:
Genetic, Environmental & Histologic Basis for Kidney Disease Risk among Persons Living with HIV
遗传、环境
- 批准号:
10405062 - 财政年份:2018
- 资助金额:
$ 65.34万 - 项目类别:
Genetic, Environmental & Histologic Basis for Kidney Disease Risk among Persons Living with HIV
遗传、环境
- 批准号:
9926023 - 财政年份:2018
- 资助金额:
$ 65.34万 - 项目类别:
Genetic, Environmental & Histologic Basis for Kidney Disease Risk among Persons Living with HIV
遗传、环境
- 批准号:
10624867 - 财政年份:2018
- 资助金额:
$ 65.34万 - 项目类别:
CKD Risk Prediction among Obese Living Kidney Donors
肥胖活体肾捐献者的 CKD 风险预测
- 批准号:
10302301 - 财政年份:2017
- 资助金额:
$ 65.34万 - 项目类别:
Long-term outcomes among living kidney donors with isolated medical abnormalities
患有孤立性医学异常的活体肾脏捐献者的长期结果
- 批准号:
9110989 - 财政年份:2015
- 资助金额:
$ 65.34万 - 项目类别:
Long-term outcomes among living kidney donors with isolated medical abnormalities
患有孤立性医学异常的活体肾脏捐献者的长期结果
- 批准号:
8966934 - 财政年份:2015
- 资助金额:
$ 65.34万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 65.34万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 65.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 65.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 65.34万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 65.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 65.34万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 65.34万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 65.34万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 65.34万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 65.34万 - 项目类别:
Standard Grant